Neupath Health (NPTH) CEO Joe Walewicz: Record Q2 Financial Results: Revenue +25% Adj EBITDA + 69% скачать в хорошем качестве

Neupath Health (NPTH) CEO Joe Walewicz: Record Q2 Financial Results: Revenue +25% Adj EBITDA + 69%

This video is produced on behalf of the presenting company. CEO Joe Walewicz, CFO Jeff Zygouras and President Stephen Lemiux. NeuPath Health Inc. (TSXV:NPTH) NEUPATH HEALTH REPORTS SECOND QUARTER 2025 RESULTS 2025-08-14 07:30 ET - Record second quarter total revenue of $23.6 million, up 25% year-over-year Positive cash flows, with Adjusted EBITDA(1) of $2.2 million, up 69% year-over-year, and our 26th consecutive quarter of positive Adjusted EBITDA Martin Gagel and Market Radius Capital, Inc. are not registered or licensed to provide investment advice. Content is for information purposes only and may include incomplete or incorrect information and is not advice or a recommendation. Communications and content from Radius Research or Market Radius Research are productions of Market Radius Capital, Inc. Martin Gagel may own shares of any of the companies mentioned. Market Radius Capital, Inc. may be compensated and may have commercial arrangements with any of the companies mentioned. Content may contain forward looking statements. Please read the presenting companies' forward looking statement disclaimers.